Viking Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for Viking Therapeutics stock have an average target of 89.75, with a low estimate of 30 and a high estimate of 138. The average target predicts an increase of 282.57% from the current stock price of 23.46.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$89.75	$102	$138
Change	+27.88%	+282.57%	+334.78%	+488.24%

Analyst Ratings

The average analyst rating for Viking Therapeutics stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	8	8	8	8	6	5
Buy	3	4	4	5	5	5
Hold	0	0	0	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	12	12	14	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Law Goldman Sachs	Goldman Sachs	Hold Initiates $30	Hold	Initiates	$30	+27.88%	Apr 8, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $102	Strong Buy	Reiterates	$102	+334.78%	Mar 26, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $102	Strong Buy	Reiterates	$102	+334.78%	Mar 11, 2025
George Farmer Scotiabank	Scotiabank	Buy Initiates $102	Buy	Initiates	$102	+334.78%	Feb 13, 2025
David Lebowitz Citigroup	Citigroup	Hold Initiates $38	Hold	Initiates	$38	+61.98%	Feb 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 795.23M

Revenue Next Year

n/a

EPS This Year

-1.63

from -1.01

EPS Next Year

-2.21

from -1.63

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	1.50M	6.58M	21.84M	212.83M	795.23M
Revenue Growth	-	338.60%	231.93%	874.59%	273.65%	-	-	-
EPS	-0.54	-0.71	-0.90	-0.91	-1.01	-1.63	-2.21	-2.61
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	18	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	26.3M	97.9M	149.4M
Avg	1.5M	6.6M	21.8M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-96.7%	6,424.0%	2,170.4%
Avg	-99.8%	338.6%	231.9%
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.03	-1.61	-0.87
Avg	-1.63	-2.21	-2.61
Low	-2.12	-3.04	-3.73

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.